论文部分内容阅读
(续22期)10正接受核苷类药物治疗的患者,如出现反跳了解患者的依从性,已长期停止药物治疗的患者应重新开始治疗(Ⅲ);如果为了鉴别是初始无应答还是反弹以及明确是否有多药耐药证据(对于曾经应用一种以上核苷类药物的患者),应进行抗病毒耐药突变检测(Ⅲ);所有发生病毒学反弹的患
(Issue 22) 10 In patients undergoing nucleoside therapy, patients who have discontinued medication for prolonged resuscitation should be restarted in the event of a rebound-aware patient compliance (III); if they are initially unresponsive or rebound And if there is evidence of multidrug resistance (for patients who have previously used more than one type of nucleoside drug) should be tested for antiviral resistance mutations (III); all patients with a virological rebound